The full results of the first randomized controlled trial show that the use of artificial intelligence in screening mammography leads to the detection of fewer advanced and aggressive breast cancers, suggesting that AI may improve the quality of early diagnosis and potentially reduce the number of advanced-stage cases.
New scientific studies indicate that nanoparticles based on rare-earth metals may have potential in the diagnosis and treatment of brain tumors, particularly glioblastoma, one of the most aggressive cancers, with a median patient survival of around 12–15 months.
Scientists have shown that inhibiting a single specific enzyme can trigger the regeneration of joint cartilage and significantly slow the progression of osteoarthritis. The study indicates that the experimental therapy worked not only in older mice, but also in models of traumatic osteoarthritis and in human cartilage tissue.
A study published in JAMA Internal Medicine found that the Donald Trump administration terminated funding for 383 ongoing clinical trials, affecting more than 74,000 participants. The cuts were part of broader budget reductions at the National Institutes of Health.